4-HYDROXYANDROSTENEDIONE ALONE AND IN COMBINATION WITH ZOLADEX IN PREMENOPAUSAL BREAST-CANCER

被引：0
作者：
STEIN, RC
DOWSETT, M
HEDLEY, A
COOMBES, RC
机构：
[1] ST GEORGES HOSP,CLIN ONCOL UNIT,LONDON SW17 0RE,ENGLAND
[2] CHELSEA HOSP WOMEN,LONDON SW3 6LT,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1989年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：824 / 824
页数：1
相关论文
共 50 条
[21]   INFLUENCE OF AMINOGLUTETHIMIDE ON PLASMA ESTROGEN-LEVELS IN BREAST-CANCER PATIENTS ON 4-HYDROXYANDROSTENEDIONE TREATMENT [J].
LONNING, PE ;
DOWSETT, M ;
JONES, A ;
EKSE, D ;
JACOBS, S ;
MCNEIL, F ;
JOHANNESSEN, DC ;
POWLES, TJ .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 23 (1-2) :57-62
[22]   A PHASE-II STUDY OF 4-HYDROXYANDROSTENEDIONE (4OHA) IN POST MENOPAUSAL BREAST-CANCER [J].
BOWMAN, A ;
STEWART, ME ;
DOWSETT, M ;
GASKELL, D ;
OBRIEN, ME ;
ECCLES, DM ;
CHETTY, U ;
RODGER, A ;
LEONARD, RCF ;
SMYTH, JF .
BRITISH JOURNAL OF CANCER, 1990, 62 (03) :521-521
[23]   MEDICAL CASTRATION WITH ZOLADEX - A CONSERVATIVE APPROACH TO PREMENOPAUSAL BREAST-CANCER [J].
BRAMBILLA, C ;
ESCOBEDO, A ;
ARTIOLI, R ;
LECHUGA, MJ ;
MOTTA, M ;
BONADONNA, G .
TUMORI, 1991, 77 (02) :145-150
[24]   TREATMENT OF ADVANCED POSTMENOPAUSAL BREAST-CANCER WITH AN AROMATASE INHIBITOR, 4-HYDROXYANDROSTENEDIONE - PHASE-II REPORT [J].
GOSS, PE ;
POWLES, TJ ;
DOWSETT, M ;
HUTCHISON, G ;
BRODIE, AMH ;
GAZET, JC ;
COOMBES, RC .
CANCER RESEARCH, 1986, 46 (09) :4823-4826
[25]   GOSERELIN (ZOLADEX) IN PREMENOPAUSAL ADVANCED BREAST-CANCER - DURATION OF RESPONSE AND SURVIVAL [J].
DIXON, AR ;
ROBERTSON, JFR ;
JACKSON, L ;
NICHOLSON, RI ;
WALKER, KJ ;
BLAMEY, RW .
BRITISH JOURNAL OF CANCER, 1990, 62 (05) :868-870
[26]   PLASMA AND URINARY ESTROGENS IN BREAST-CANCER PATIENTS ON TREATMENT WITH 4-HYDROXYANDROSTENEDIONE (VOL 68, PG 393, 1993) [J].
JOHANNESSEN .
BRITISH JOURNAL OF CANCER, 1994, 69 (03) :626-626
[27]   LHRH AGONIST ZOLADEX AND ANTI-ESTROGEN TAMOXIFEN - A RATIONAL COMBINATION IN PREMENOPAUSAL WOMEN WITH BREAST-CANCER [J].
ROBERTSON, JFR ;
WALKER, K ;
NICHOLSON, RI ;
BLAMEY, RW .
BRITISH JOURNAL OF SURGERY, 1988, 75 (12) :1271-1271
[28]   DOSE-RELATED ENDOCRINE EFFECTS AND PHARMACOKINETICS OF ORAL AND INTRAMUSCULAR 4-HYDROXYANDROSTENEDIONE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS [J].
DOWSETT, M ;
CUNNINGHAM, DC ;
STEIN, RC ;
EVANS, S ;
DEHENNIN, L ;
HEDLEY, A ;
COOMBES, RC .
CANCER RESEARCH, 1989, 49 (05) :1306-1312
[29]   4-HYDROXYANDROSTENEDIONE (4-OHA) AS 2ND LINE HORMONAL-THERAPY IN ADVANCED BREAST-CANCER [J].
MURRAY, PA ;
PERRY, L ;
GILMORE, J ;
PLOWMAN, PN .
BRITISH JOURNAL OF CANCER, 1988, 58 (04) :534-534
[30]   AROMATASE INHIBITION WITH 4-HYDROXYANDROSTENEDIONE IN THE TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A PHASE-II STUDY [J].
HOFFKEN, K ;
JONAT, W ;
POSSINGER, K ;
KOLBEL, M ;
KUNZ, T ;
WAGNER, H ;
BECHER, R ;
CALLIES, R ;
FRIEDERICH, P ;
WILLMANNS, W ;
MAASS, H ;
SCHMIDT, CG .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) :875-880
12345